Stimulator of interferon genes
From Proteopedia
(Difference between revisions)
| Line 1: | Line 1: | ||
<StructureSection load='4ef4' size='350' side='right' caption='Structure of human STING CTD complex with c-di-GMP (stick model) and Ca+2 ion (green) (PDB entry [[4ef4]])' scene=''> | <StructureSection load='4ef4' size='350' side='right' caption='Structure of human STING CTD complex with c-di-GMP (stick model) and Ca+2 ion (green) (PDB entry [[4ef4]])' scene=''> | ||
| - | '''Stimulator of interferon genes''' (STING) induces production of type I interferon when cells are infected by viruses, mycobacteria and intracellular parasites. STING recognizes and binds cyclic-di-GMP produced by bacteria and cyclic-GMP AMP (cGAMP) produced by viruses. The C-terminal domain (CTD) (residues 139-379 in human) of STING binds cyclic-di-GMP. STING is a facilitator of innate immune signaling. | + | '''Stimulator of interferon genes''' (STING) induces production of type I interferon when cells are infected by viruses, mycobacteria and intracellular parasites. STING recognizes and binds cyclic-di-GMP produced by bacteria and cyclic-GMP AMP (cGAMP) produced by viruses. The C-terminal domain (CTD) (residues 139-379 in human) of STING binds cyclic-di-GMP. STING is a facilitator of innate immune signaling<ref>PMID:26980676</ref>. |
</StructureSection> | </StructureSection> | ||
| Line 26: | Line 26: | ||
**[[4qxo]], [[4qxp]], [[4qxq]], [[4qxr]] – hSTING CTD + chemptherapeutic agent DMXAA<br /> | **[[4qxo]], [[4qxp]], [[4qxq]], [[4qxr]] – hSTING CTD + chemptherapeutic agent DMXAA<br /> | ||
}} | }} | ||
| + | == References == | ||
| + | <references/> | ||
[[Category:Topic Page]] | [[Category:Topic Page]] | ||
Revision as of 09:28, 1 September 2016
| |||||||||||
3D structures of STING
(Updated on 01-September-2016
References
- ↑ Poltorak A, Kurmyshkina O, Volkova T. Stimulator of interferon genes (STING): A "new chapter" in virus-associated cancer research. Lessons from wild-derived mouse models of innate immunity. Cytokine Growth Factor Rev. 2016 Jun;29:83-91. doi:, 10.1016/j.cytogfr.2016.02.009. Epub 2016 Mar 4. PMID:26980676 doi:http://dx.doi.org/10.1016/j.cytogfr.2016.02.009
